05-Jan-2021

Charles River Laboratories International, Inc. announced that it acquired of Distributed Bio, Inc. on December 31, 2020. The acquisition marks the culmination of an exclusive partnership between these companies that was initiated in October 2018. Based in South San Francisco, California, ...

more

18-Dec-2019

Charles River Laboratories International, Inc. and HemaCare Corporation announced a definitive agreement for Charles River to acquire HemaCare for approximately $380 million in cash. HemaCare is a leader in the production of human-derived cellular products for the cell therapy market. The ...

more

18-Feb-2019

Charles River Laboratories International, Inc. announced that it has signed a binding offer to acquire Citoxlab for €448 million in cash (or approximately $510 million based on current exchange rates), subject to customary closing adjustments. The proposed transaction is expected to close in the ...

more

15-Feb-2018

Charles River announced that it has entered into a definitive agreement to acquireMPI Researchfor approximately$800 millionin cash, subject to customary closing adjustments. MPI is a premier non-clinical contract research organization (CRO) providing comprehensive testing services to ...

more

30-Sep-2016

Charles River Laboratories International, Inc. announced that it has acquired Agilux Laboratories, Inc., a Worcester, Massachusetts-based contract research organization (CRO), that provides a suite of integrated discovery small and large molecule bioanalytical services, drug metabolism and ...

more

29-Jun-2016

Charles River Laboratories Acquires Blue Stream Laboratories Charles River Laboratories International announced that it has acquired Blue Stream Laboratories, Inc. Combining Blue Stream with Charles River’s existing discovery, safety assessment, and biologics capabilities creates a leading ...

more

Expands Oncology Capabilities of Charles River Discovery Services

20-Nov-2015

Charles River Laboratories International, Inc. announced today that it has acquired Oncotest GmbH, a Freiburg, Germany-based contract research organization (CRO) providing discovery services for oncology, one of the largest therapeutic areas for biopharmaceutical research and development ...

more

02-Nov-2011

Protagen AG and Charles River Laboratories International, Inc. are announce a strategic Marketing & Sales alliance. For Charles River Biopharmaceutical Services (BPS) the fast-growing demand for biopharmaceuticals testing requires an expert partner with a broad range of services. Charles River ...

more

29-Aug-2007

Charles River Laboratories International, Inc. announced that it intends to build a new facility in Sherbrooke, Quebec, to support the company's expanding Preclinical Services business. Located in the newly constructed Sherbrooke Biomedical Park, Charles River's newest facility shall provide ...

more

12-Apr-2007

Charles River Laboratories announced the establishment of Charles River Endosafe Korea. Effective May 1, 2007, Endosafe®products will be sold and supported directly by the new, wholly owned Korean operation. The focus of Endosafe Korea's scientific staff will be to promote and ensure regulatory ...

more